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Abstract: Background: Breastfeeding is associated with short and long-term health benefits.
Long-term effects might be mediated by epigenetic mechanisms, yet the literature on this topic is scarce.
We performed the first epigenome-wide association study of infant feeding, comparing breastfed vs
non-breastfed children. We measured DNA methylation in children from peripheral blood collected
in childhood (age 7 years, N = 640) and adolescence (age 15–17 years, N = 709) within the Accessible
Resource for Integrated Epigenomic Studies (ARIES) project, part of the larger Avon Longitudinal
Study of Parents and Children (ALSPAC) cohort. Cord blood methylation (N = 702) was used as a
negative control for potential pre-natal residual confounding. Results: Two differentially-methylated
sites presented directionally-consistent associations with breastfeeding at ages 7 and 15–17 years,
but not at birth. Twelve differentially-methylated regions in relation to breastfeeding were identified,
and for three of them there was evidence of directional concordance between ages 7 and 15–17 years,
but not between birth and age 7 years. Conclusions: Our findings indicate that DNA methylation in
childhood and adolescence may be predicted by breastfeeding, but further studies with sufficiently
large samples for replication are required to identify robust associations.
Keywords: breastfeeding; life-course; DNA methylation; epigenome-wide association study
1. Background
Breastfeeding has clear short-term health benefits, particularly in reducing the risk of infections in
childhood. Accumulating evidence indicates that breastfeeding may also have long-term effects on
health outcomes and human capital, as well as benefit maternal health [1]. Being breastfed has been
associated with lower risk of being overweight or obese and having type 2 diabetes in adulthood in the
most recent meta-analysis based on a systematic literature review [2]. Moreover, it has been suggested
that being breastfed has a positive effect on cognitive development in studies using complementary
epidemiological approaches [3–5]. However, it should be noted that the single large randomized
controlled trial of breastfeeding promotion did not support a causal effect of breastfeeding on obesity
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in childhood and adolescence [6,7], and on metabolic processes related to type 2 diabetes (such as
blood glucose and insulin) in childhood [8]. The same trial indicated that the effect of breastfeeding on
cognitive development in childhood is attenuated over time [4,9]. However, a single trial does not
fully dismiss many high-quality observational studies (especially those conducted in different contexts
from that of the trial and/or when using different designs—and, therefore, prone to different potential
bias sources—yield similar conclusions). In summary, definitive conclusions on the long-term effects
of breastfeeding cannot be drawn from the current epidemiological evidence.
The mechanisms underlying the putative long-term effects of breastfeeding are not fully
understood. Such mechanisms clearly must persist over time after weaning—in other words,
become embodied in the organism [10]. In the case of other early-life exposures such as maternal
smoking during pregnancy, there is evidence of long-term associations with offspring DNA
methylation [11]—i.e., addition of a methyl (–CH3) group to DNA at the 5′ position of a cytosine base,
typically in cytosine-guanine (CpG) dinucleotides [12]. DNA methylation is one type of a broader class
of biological processes known as epigenetics, which encompasses mitotically heritable events—other
than changes in the DNA sequence itself—involved in gene expression regulation. Epigenetic processes
play a key role in developmental processes [13,14], and have more recently been linked to disease
processes [15–17], although causal claims have been overstated in many cases [18,19].
Some evidence suggests that breastfeeding might influence DNA methylation through the effects
of some of its nutritional components [20] or through the microbiome, which is shaped by early feeding
habits [21]. However, according to a systematic literature review [22] the overall evidence on the
potential effects of breastfeeding on DNA methylation is scarce and reports of differences in DNA
methylation according to breastfeeding are only emerging in the literature [23–27]. Our aim was to
perform a genome-wide assessment of the association between breastfeeding and DNA methylation in
childhood, characterize—if present—the pattern of this association and investigate whether it persists
until adolescence in a population-based study in England.
2. Methods
2.1. Study Setting and Participants
Study subjects were part of the Accessible Resource for Integrated Epigenomic Studies (ARIES) [28],
a sub-sample of the Avon Longitudinal Study of Parents and Children (ALSPAC) for which methylation
data were collected. ALSPAC is a population-based, prospective birth cohort of women and their
children [29–31]. All pregnant women living in the geographical area of Avon (UK) with expected
delivery date between 1 April 1991 and 31 December 1992 were invited to participate. Approximately
85% of the eligible population was enrolled, totalling 14,541 pregnant women who gave informed
and written consent. Information on the data collection and availability can be found at http:
//www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/. Ethical approval for the study was
obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees.
Our analysis was focused on the offspring born between 1991 and 1992. The analyses were
restricted to singletons or only to one participant out of a twin pair (N = 2 twin pairs), selected at
random. Individuals with missing information for the exposure, outcome or covariates (described
below) were excluded.
Individual-level data were obtained from the ALSPAC study according to the ALSPAC data access
procedures and policies detailed at http://www.bristol.ac.uk/alspac/researchers/access/.
Nutrients 2020, 12, 3309 3 of 17
2.2. Study Variables
2.2.1. DNA Methylation
DNA methylation in white blood cells was measured in ARIES offspring at three time points:
at birth (cord blood), and at 7 and 15–17 years of age (peripheral blood). DNA samples underwent
bisulphite conversion using the Zymo EZ DNA methylationTM kit (Zymo, Irvine, CA, USA).
The Illumina HumanMethylation450 BeadChip was used for genome-wide epigenotyping. The arrays
were scanned using an Illumina iScan, and initial quality checks performed using GenomeStudio
(Illumina, Inc., 5200 Illumina Way, San Diego, CA 92122, USA) version 2011.1. A total of 71 samples
across all the time-points were analysed in duplicates to ensure the technical validity of the arrays.
We excluded single nucleotide polymorphisms, probes with a high detection p-value (i.e., p-value > 0.05
in more than 5% samples) and sex chromosomes. Methylation data normalisation was carried out
using the “Tost” algorithm to minimise non-biological between-probe differences [32], as implemented
in the “watermelon” R package [33]. All processing steps used the “meffil” R package [34].
The outcome variables of this study were cord and peripheral blood (ages 7 and 15) DNA
methylation levels in ~470,000 CpG sites. Methylation was analysed as beta values, which vary from 0
to 1 and indicate the proportion of cells methylated at a particular CpG [35]. Regression coefficients
and standard errors were multiplied by 100, so that they can be interpreted as percent point differences
in average DNA methylation at a given CpG site.
2.2.2. Breastfeeding
Breastfeeding data were collected through questionnaires answered by the mothers when their
offspring were (on average) four weeks, six months and 15 months old, and combined into four
different breastfeeding categorisations:
• A binary indicator of whether the individual was ever breasted (regardless of duration).
• Breastfeeding duration groups, defined as follows: 0 = never breastfed; 1 = 1 day to 3 months of
duration; 2 = 3.01 to 6 months; 3 = 6.01 to 12 months; and 4 = more than 12 months.
• Same as the above but coding each category as a number and treating this as a continuous variable,
thus assuming a linear trend per unit increase in duration category.
• Breastfeeding duration in months, as a continuous variable, thus assuming a linear trend per
month increase in breastfeeding duration.
2.2.3. Covariates
Covariates were selected mostly based on a conceptual model encoded in the form of a directed
acyclic graph (DAG) that we defined previously [27]. The following covariates were used:
• Sociodemographic: an indicator of whether the participant had white ethnic background (informed
by mothers at 32 weeks of gestation), and the top two ancestry-informative principal components
estimated using the participant’s genome-wide genotyping data [36].
• Family socioeconomic position: to avoid collinearity issues, we used only the mother’s highest
educational qualification (informed by the mothers themselves at 32 weeks of gestation).
• Maternal characteristics: parity (informed by the mothers at 18 weeks of gestation), height,
pre-pregnancy weight (informed by the mothers themselves at 12 weeks of gestation), age at
birth (calculated from mother’s date of birth and date of delivery) and folic acid supplementation
(informed by the mothers at 18 and 32 weeks of gestation).
• Gestational characteristics: maternal smoking during pregnancy (informed by the mothers at
18 weeks of gestation), type of delivery (informed by the mothers when their offspring were eight
weeks old), gestational age (calculated from the date of the mother’s last menstrual period reported
at enrolment; when the mother was uncertain of this or when it conflicted with clinical assessment,
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the ultrasound assessment was used; where maternal report and ultrasound assessment conflicted,
an experienced obstetrician reviewed clinical records and provided an estimate) and birthweight
(from obstetric data, measures from the ALSPAC team and notifications or clinical records).
Although not included in the DAG, participant’s sex and age at blood collection were also
selected as covariates. Given that they are associated with DNA methylation but are not influenced
by breastfeeding, adjusting for those two covariates may improve power by reducing variance in
DNA methylation. We also adjusted for estimated cell counts using Bakulski’s [37] (for cord blood) or
Houseman’s (for peripheral blood) [38] methods to account for methylation differences due to cell
composition. Finally, a surrogate variable analysis was performed on the methylation data using the
“sva” R package. For each timepoint 10 surrogate variables were created and those not associated with
breastfeeding were additionally included as covariates to adjust for batch effects [39].
2.2.4. Statistical Analyses
We conducted an epigenome-wide association study (EWAS) of any reported breastfeeding
(including mixed breast- and formula-feeding and in combination with other foods). The main EWAS
analyses considered breastfeeding as the exposure in two categorisations: (i) none vs. any; (ii) duration
categories, assuming a linear trend.
The outcome was DNA methylation measured at ~470,000 CpG sites in peripheral blood at the
age of 7 years. The analyses were performed on the subjects with complete covariate data available
(N = 702) adjusting for estimated cell composition, batch effects, and all other covariates. In all
models we measured the association between breastfeeding and DNA methylation at each CpG
using robust linear regression models (“rlm” function in the “MASS” R package) and tested the
association by computing heteroskedasticity-consistent standard errors (“coeftest” function in the
“lmtest” R package with the variance-covariance option vcovHC, type = “HC0”, from the “sandwich”
R package). The association of methylation at CpGs at age 7 and breastfeeding was evaluated by
looking at p-values corrected for the false-discovery rate (FDR) using the Benjamini and Hochberg
method [40]. Associations with at least suggestive evidence, here defined as achieving a nominal
p-value < 5.0 × 10−6, were further analysed using breastfeeding duration variable as exposure (either 4
categories or continuous duration).
Sensitivity analyses were further conducted to explore a potential dose-response relationship in
the association of breastfeeding with DNA methylation at the suggestive sites at age 7. Breastfeeding
duration during the first 3 months was categorised by 2-week increments (exposure) compared to
the reference (no breastfeeding) and DNA methylation at age 7 at the suggestive sites (outcome).
A further categorisation considered mixed breast-/formula feeding and exclusive breastfeeding in
the first 3 months of age, compared with no breastfeeding. As the main source of food in the first
3 months of age is milk, these categories can be described approximately as “No breastfeeding”,
“Mixed breast-/formula” and “Exclusive breastfeeding”. To further test the strength of the association
between breastfeeding and methylation, conditional on lipid profiles, we ran the analysis on the
suggestive sites with further adjustment for serum lipid profiles in the mothers and the children,
separately. The lipid profiles consisted of serum total cholesterol, total cholesterol in very-low-density
lipoproteins, total cholesterol in low-density lipoproteins, total cholesterol in high-density lipoproteins
and serum total triglycerides. All the lipid fractions were measured using the Nightingale Health
NMR-based blood biomarker analysis platform [41] in blood collected from the mothers during
pregnancy and from the children at age 7. Lipid concentrations were expressed in mmol/L. To rule out
a potential confounding effect of gestational methylation age we computed a gestational age score
based on DNA methylation in cord blood using a published algorithm in Bohlin et al. [42] which
was previously applied to ALSPAC data and found to correlate well with measured gestational age
(r = 0.65) [43].
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At the CpGs with suggestive evidence we also investigated whether the signal persisted over
time by analysing the association of CpG methylation at age 15–17 and breastfeeding (ever vs never
and duration categories). Cord blood methylation was analysed as a negative control [44], under the
assumption that at least some of possible pre-natal residual confounding would result in associations
between breastfeeding and cord blood methylation.
All follow-up analyses were performed using robust linear regression and
heteroskedasticity-consistent standard errors (implemented as described above).
The EWAS results were further used to identify differentially methylated regions (DMRs) in
relation to breastfeeding. DMRs were identified using the Comb-P method, which tags regions
enriched for low p-values while accounting for auto-correlation and multiple testing [45,46]. Following
the criteria used by Sharp et al. [47], a region was classified as a DMR if: (i) it contained at least
two CpGs; (ii) all CpGs in the region are within 1000 bp of at least another CpG in the same region;
and (iii) the auto-correlation and multiple-testing corrected (upon applying Stouffer-Liptak-Kechris [48]
and Sidak methods [49], respectively) p-value for the region was <0.05. The CpGs belonging to the
identified DMRs were analysed further to assess if breastfeeding had a consistent effect across the
DMR (i.e., if CpGs in the DMR generally presented greater or lower levels of methylation according to
breastfeeding) using linear mixed models to account for the correlation between CpGs assuming that
they are nested within individuals. Therefore, each CpG in a given DMR was treated as a repeated
measure of DNA methylation, and the regression coefficient indicates the average difference in DNA
methylation levels comparing breastfed and never breastfed individuals, averaging across all CpGs in
the DMR. This was implemented using the “nlme” R package. This was complemented by evaluating,
for each DMR, the directional consistency of each CpG across time points using a sign test. Analyses
were performed using R 3.4 (R Core Team (2018). R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna, Austria https://www.R-project.org).
The scripts used are available on request to the study authors.
3. Results
3.1. Description of Study Participants
Table 1 and Table S1 display the characteristics of the study participants with DNA methylation
data at age 7 (N = 702) and non-missing information for all study variables (corresponding to
approximately 70% of all ARIES participants). In general, the subset included in our analysis was
similar to the entire ARIES dataset. The largest differences were observed for maternal education at
birth (with the mothers of included individuals having slightly higher educational attainment) and
ethnicity (with the proportion of individuals of white ethnic background being slightly higher in the
included individuals). Previous analyses indicated that ARIES is reasonably representative of the entire
ALSPAC cohort [28]. At the other timepoints the sample size differed slightly: there were 640 (birth)
and 709 (age 15–17) participants.
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Table 1. Description of the individuals included in the main analysis (ARIES participants with age 7
methylation data and all covariates).
Variable Statistic/Category a All ARIESParticipants (N = 995)
Participants
with Methylation at Age 7 (N = 702)
Maternal education CSE 8.9% 7.2%
at birth Vocational education 7.4% 6.0%
GCE Ordinary level 34.3% 33.8%
GCE Advanced level 29.1% 29.9%
Degree 20.3% 23.1%
Maternal age at birth (years) Mean (SD) 29.5 (4.4) 30.0 (4.4)




Maternal smoking Never 86.3% 87.7%
in relation to Before 3.7% 4.0%
pregnancy During 10.0% 8.3%
Folic acid No 75.9% 75.9%
supplementation Yes 24.1% 24.1%
Caesarean section No 90.4% 90.2%
Yes 9.6% 9.8%
Birthweight (g) Mean (SD) 3487 (486) 3490 (476)
Sex Male 48.9% 49.1%
Female 51.1% 50.9%
Ethnicity European 97.0% 99.9%
Other 3.0% 0.1%
Breastfeeding duration 0 11.1% 10.4%




a Mean and SD for continuous variables, and each category (for which proportions are shown) for categorical
variables. CSE: Certificate of Secondary Education. GCE: General Certificate of Education. SD: standard deviation.
3.2. Association of Breastfeeding with Single CpG Sites
Figure 1 provides an overall view of the EWAS results. There was no strong indication of
genome-wide inflation for breastfeeding analysed in duration categories, assuming a linear trend
(genomic inflation factor of 0.97), but there was some indication for the “ever breastfeeding” variable
(genomic inflation factor of 1.10). Importantly, the bulk of the distribution closely resembled the
expected under the null, with the deviation occurring in the right tail of the distribution of p-values.
This may be due to breastfeeding having small effects on DNA methylation (in which case detection
would require larger samples) in many regions of the genome, rather than due to the presence of
systematic bias in the results.
Regarding ever breastfeeding (Table 2), one CpG (cg11414913) achieved FDR < 0.05, and there
was suggestive evidence of association for six additional sites (cg00234095, cg04722177, cg03945777,
cg17052885, cg05800082 and cg24134845; see Table S6 for a description of those CpGs). None of the sites
were located in array probes with potential to cross-hybridize to multiple genomic regions according
to Naeem et al. [50]. The results for breastfeeding coded as a categorical variable in duration categories
(assuming a linear trend) were null, with no CpGs achieving even suggestive levels of association.
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Figure 1. Manhattan (A,C) and Q-Q plots (B,D) of the breastfeeding EWAS at age 7. In (A,B), methylation
was compared between never vs. ever breastfed individuals; in (C,D) methylation was compared
according to breastfeeding duration (in categories, assuming a linear trend). Both models were adjusted
for cell composition, batch, child genetic ancestry (two principal components), mother’s education,
parity, age at birth, f lic acid supplementation, maternal smoking, gestational age, type of delivery,
birthweight, chil sex and age at blood collection.
Table 2 shows that methylation in the cg11414913 CpG was 3.2 per ent points lower (p = 5.2 × 10−8)
in ever breastfed children. There was also suggestive evidence for an association between breastfeeding
and lower methylation in the cg00234095 (β=−1.7; p = 4.9× 10−7), cg04722177 (β=−2.9; p = 2.7 × 10−6),
and cg03945777 (β = −0.8; p = 3.2 × 10−6) sites, and for higher methylation in the cg17052885 (β = 1.8;
p = 4.9 × 10−6), cg05800082 (β = 1.1; p = 5.8 × 10−6), and cg24134845 (β = 0.2; p = 3.3 × 10−5) sites.
The evidence of an association was greatly attenuated when breastfeeding was analysed continuously
(in months), and the regression coefficients were generally similar among different categories of
breastfeeding duration. The sensitivity analysis using breastfee i g duration categories by 2-week
increm nts in the first 3 months of age (Table S2) showed no clear trend in the regression estimates
comparing each duration category to no breastfeeding. The i troduction of formula in t first
3 months did not seem to alter the association of breastfeeding with DNA methylation, as shown
in Table S3. Further adjustment for lipid profiles did not substantially influence the beta estimates
of the association between breastfeeding and DNA methylation at age 7 (Table S4). Furthermore,
DNA methylation at the suggestive CpGs was not associated with gestational age methylation score
(Table S5). Altogether, these results indicate that the association between breastfeeding and peripheral
blood DNA methylation is unlikely to follow a dose-response relationship but presents a threshold
(ever vs. never) pattern.
Nutrients 2020, 12, 3309 8 of 17
Table 2. Average percent point differences (β) in DNA methylation at age 7 (N = 640) according to breastfeeding.
Breastfeeding Statistic
CpG
cg11414913 cg00234095 cg04722177 cg03945777 cg17052885 cg05800082 cg24134845
Binary (ever
vs. never)
p-value 5.2 × 10−8 4.9 × 10−7 2.7 × 10−6 3.2 × 10−6 4.9 × 10−6 5.8 × 10−6 3.3 × 10−5
β (SE) −3.19 (0.59) −1.74 (0.35) −2.90 (0.62) −0.84 (0.18) 1.79 (0.39) 1.05 (0.23) 0.23 (0.06)
0 (reference) p-value - - - - - - -
β (SE) - - - - - - -
0.01–3 months
p-value 1.5 × 10−6 1.2 × 10−7 5.3 × 10−4 2.9 × 10−5 8.2 × 10−6 1.7 × 10−6 6.8 × 10−5
β (SE) −3.19 (0.66) −2.02 (0.38) −2.45 (0.71) −0.85 (0.20) 1.85 (0.41) 1.19 (0.25) 0.25 (0.06)
3.01–6 months
p-value 5.4 × 10−7 3.3 × 10−5 5.8 × 10−5 0.005 6.8 × 10−5 6.4 × 10−4 0.011
β (SE) −3.50 (0.70) −1.88 (0.45) −3.22 (0.80) −0.66 (0.23) 1.85 (0.47) 0.94 (0.28) 0.17 (0.07)
6.01–12 months
p-value 2.5 × 10−5 3.2 × 10−4 5.9 × 10−5 7.4 × 10−5 6.1 × 10−6 0.001 2.2 × 10−4
β (SE) −3.00 (0.71) −1.59 (0.44) −3.05 (0.76) −0.90 (0.23) 2.02 (0.45) 0.87 (0.27) 0.24 (0.06)
>12 months
p-value 5.8 × 10−4 0.037 1.1 × 10−6 1.2 × 10−4 0.008 0.001 4.4 × 10−4
β (SE) −2.96 (0.86) −0.93 (0.44) −3.79 (0.78) −0.99 (0.26) 1.29 (0.49) 1.04 (0.31) 0.25 (0.07)
Linear trend
of categories
p-value 0.036 0.832 1.7 × 10−4 0.007 0.067 0.230 0.020
β (SE) −0.42 (0.20) −0.02 (0.11) −0.70 (0.19) −0.16 (0.06) 0.19 (0.10) 0.08 (0.07) 0.04 (0.02)
Continuous
(in months)
p-value 0.080 0.766 2.5 × 10−4 0.035 0.966 0.399 0.289
β (SE) −0.09 (0.05) 0.01 (0.03) −0.18 (0.05) −0.03 (0.02) 0.00 (0.03) 0.01 (0.02) 0.00 (0.00)
SE: standard error.
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Table 3 displays the association between ever breastfeeding and peripheral blood methylation
at different ages in the CpGs identified in the EWAS. The cg11414913 CpG presented a persistent,
directionally-consistent association with breastfeeding at the age of 15–17 years (β = −2.8; p = 0.004),
and no strong evidence of association at birth (β = −0.4; p = 0.631). The cg05800082 CpG presented a
similar pattern, although the point estimate was attenuated compared to age 7 years, and presented
rather weak statistical evidence of association at the age of 15–17 years (β = 0.6; p = 0.083). However,
it was reassuring that its point estimate at birth (β = −0.5; p = 0.144) was directionally inconsistent
with the results at later ages. The CpGs cg00234095, cg03945777 and cg24134845 presented evidence
of association at age 7, but neither at birth nor at age 15–17, suggesting a true association with
breastfeeding that does not persist until the ages of 15–17. DNA methylation at birth in the two
remaining CpGs was associated with breastfeeding in the same direction as the association at the age
of 7, suggesting that those associations are substantially influenced by some unaccounted bias source
(e.g., unmeasured confounders).
Table 3. Average percent point differences (β) in DNA methylation at different ages according
to breastfeeding.
CpG Time Point β SE p-Value
cg11414913 At birth (N = 702) −0.44 0.91 0.631
7 years (N = 640) −3.19 0.59 5.2 × 10−8
15–17 years (N = 709) −2.47 0.85 0.004
cg00234095 At birth (N = 702) 0.59 0.57 0.296
7 years (N = 640) −1.74 0.35 4.9 × 10−7
15–17 years (N = 709) 0.29 0.43 0.505
cg04722177 At birth (N = 702) −1.50 0.70 0.032
7 years (N = 640) −2.90 0.62 2.7 × 10−6
15–17 years (N = 709) −1.05 0.78 0.180
cg03945777 At birth (N = 702) 0.42 0.3 0.158
7 years (N = 640) −0.84 0.18 3.2 × 10−6
15–17 years (N = 709) 0.10 0.29 0.742
cg17052885 At birth (N = 702) 1.32 0.57 0.022
7 years (N = 640) 1.79 0.39 4.9 × 10−6
15–17 years (N = 709) −0.29 0.47 0.547
cg05800082 At birth (N = 702) −0.53 0.36 0.144
7 years (N = 640) 1.05 0.23 5.8 × 10−6
15–17 years (N = 709) 0.56 0.32 0.083
cg24134845 At birth (N = 702) 0.04 0.07 0.535
7 years (N = 640) 0.23 0.06 3.3 × 10−5
15–17 years (N = 709) 0.00 0.08 0.991
SE: standard error.
3.3. Association between Breastfeeding and Methylation Regions
Given that the QQ-plots were suggestive of small effects of breastfeeding on DNA methylation
in many regions of the genome, we complemented the ever breastfeeding EWAS with a search for
differentially methylated regions (DMRs)—i.e., two or more CpGs enriched for low p-values of the
association with breastfeeding (see the Methods for details). In total, 12 DMRs were identified at age
7 (Table 4 and Table S7). There was no strong indication that the association of breastfeeding with
different CpGs in the same DMR was generally directionally consistent (Table 4).
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Table 4. Association between peripheral blood DNA methylation at different ages at each DMR and
ever breastfeeding.
DMR a At birth 7 Years 15–17 Years
Chr Start End β SE p-Value β SE p-Value β SE p-Value
5 97,867 98,797 0.30 0.21 0.146 0.43 0.21 0.043 0.30 0.21 0.158
19 365,914 366,989 −0.01 0.34 0.975 0.05 0.34 0.881 −0.04 0.35 0.897
18 106,178 106,850 −0.08 0.77 0.913 0.14 0.75 0.855 0.23 0.77 0.767
1 425,524 426,297 0.26 0.62 0.673 0.33 0.61 0.590 0.16 0.62 0.800
9 91,296 92,146 −0.10 0.33 0.759 −0.18 0.33 0.578 −0.10 0.34 0.755
17 222,498 222,991 −0.01 0.37 0.983 0.00 0.36 0.994 −0.04 0.36 0.913
4 136,643 137,027 −0.03 0.41 0.951 −0.37 0.38 0.324 −0.31 0.41 0.448
22 255,590 256,045 0.40 0.71 0.577 1.18 0.70 0.095 1.06 0.71 0.136
4 33,482 33,808 0.13 2.05 0.950 0.06 2.00 0.978 0.08 2.04 0.967
8 409,905 410,098 0.82 1.31 0.530 1.05 1.32 0.425 1.04 1.32 0.433
1 224,191 225,190 0.03 0.45 0.940 −0.03 0.44 0.951 −0.03 0.45 0.948
9 61,093 61,964 −0.39 0.50 0.432 −0.44 0.49 0.369 −0.39 0.50 0.435
Regression coefficients (β) are average percent point differences in DNA methylation averaged across CpGs that
belong to the DMR. P-values are computed for the change in methylation across all CpGs within a DMR. This analysis
was performed using linear mixed models to account for the correlation between CpGs in the same DMR. a Human
Genome Assembly GRCh37. Chr: Chromosome. DMR: differentially methylated region. SE: standard error.
When we checked the stability of the associations over time, four DMRs presented
evidence of concordance between 7 and 15–17 years, but not between methylation at birth
and at age 7 (chromosome:position): 18:106,178–106,850, 9:91296–92146, 22:255,590–256,045,
and 8:409,905–410,098 (Table 5). For two DMRs (5:97,867–98,797 and 1:425,524–426,297), there was
evidence for directional concordance between birth and 7 years of age, suggesting that the associations
between breastfeeding and methylation at age 7 in the CpGs in those DMRs may be distorted by
pre-natal confounders. For the remaining six DMRs, there was no evidence for directional concordance
between any of the two comparisons, suggesting that the association between breastfeeding and
methylation at age 7 in the CpGs in those DMRs may be transient (i.e., childhood specific) or false
positives. A sensitivity analysis considering only those CpGs that achieved p < 0.05 in at least one
time point corroborated the strongest directional consistency between 7 and 15–17 years observed for
the four aforementioned DMRs, except the 8:409,905–410,098; importantly, this analysis involved only
three CpGs for this DMR (Table S8). Moreover, a fifth DMR—9:365,914–366,989—was identified in
this analysis, suggesting that CpGs with weak associations could have diluted the association in the
analysis considering all CpGs in the DMR.
Table 5. Directional concordance between time points for each individual CpG belonging to the
same DMR.
DMR a Number At Birth and 7 Years 7 Years and 15–17 Years
Chr Start End of CpGs Concordance p-Value Concordance p-Value
5 97,867 98,797 275 66.2 8.7 × 10−8 69.1 2.2 × 10−10
19 365,914 366,989 205 47.8 0.576 54.1 0.264
18 106,178 106,850 18 72.2 0.096 83.3 0.008
1 425,524 426,297 64 68.8 0.004 56.3 0.382
9 91,296 92,146 185 54.1 0.303 58.4 0.027
17 222,498 222,991 140 55.7 0.205 49.3 0.933
4 136,643 137,027 13 69.2 0.267 61.5 0.581
22 255,590 256,045 30 63.3 0.200 83.3 3.3 × 10−4
4 33,482 33,808 5 60.0 0.999 60.0 0.999
8 409,905 410,098 7 85.7 0.125 100.0 0.016
1 224,191 225,190 129 57.4 0.113 47.3 0.597
9 61,093 61,964 91 57.1 0.208 56.0 0.294
Concordance is shown in %. The analyses were performed using a sign test. a Human Genome Assembly GRCh37.
Chr: Chromosome. DMR: differentially methylated region.
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4. Discussion
In this epigenome-wide association study, having ever been breastfed was associated with
peripheral blood methylation in the cg11414913 CpG at ages 7 and 15–17 years, but not at birth.
There was suggestive evidence of association between ever been breastfed and age 7 methylation in six
additional CpGs, with one—the cg05800082 CpG—also presenting a directionally consistent (although
attenuated) point estimate at age 15, but not at birth. Moreover, 12 DMRs were identified at age 7,
and three of them presented evidence of directional concordance between ages 7 and 15–17, but not
between birth and age 7, in all sensitivity analyses. Our QQ-plots indicated that the associational effect
estimates between ever breastfeeding and peripheral blood DNA methylation are generally small.
Our analyses did not support a dose-response relationship between breastfeeding and peripheral
blood DNA methylation, but were consistent with an effect that depends on whether or not the child
was ever breastfed.
The epidemiological literature on breastfeeding and health focuses on well-established effects
against infectious diseases, as well as putative long-term effects on obesity, diabetes and cognitive
development, among other outcomes [1]. In the present analyses, only one site where methylation
differences were detected could be involved in the above traits. Specifically, an online search into
the biological role of the genes whose methylation was associated with breastfeeding (see Table S6)
showed an effect on the dystonin (DST) gene, which is expressed in the brain and other tissues
(www.gtextportal.org, accessed on 2 February 2019). In neural cells, DST (also known as BPAG1)
isoforms act as cytoskeletal linker proteins that anchor neural intermediate filaments to the actin
cytoskeleton [51]. Alterations in these neuronal functions could link breastfeeding to its putative
benefits on cognitive development, although this remains speculative. Other sites affected were not
located on genes with known function or were in genes expressed in other tissues such as testis. This may
be due to analysing a surrogate tissue, limited statistical power to detect more CpGs, and limited
knowledge about the health effects of the methylation sites that were detected. cg11414913, which
showed the most robust evidence of association with breastfeeding, is located in an intergenic region
with seemingly regulatory properties, as indicated by a conserved region hypersensitive to DNAses.
Its nearest gene encodes for Tetratricopeptide Repeat Protein 34 (TTC34), which is overexpressed in
the testis. However, it is unclear if there is indeed any relationship between these biological features of
cg11414913 and the effects of breastfeeding, an issue that thus requires further investigation. Moreover,
the effects of breastfeeding on health and development may be mediated through other epigenetic
processes, such as non-coding RNAs [52,53], as well as a host of mechanisms other than epigenetics,
including provision of nutrients (e.g., pre-formed long-chain polyunsaturated fatty acids, which is
a plausible mediator of the benefits on IQ [54]), antibodies and other immunoactive compounds,
antimicrobials, and important effects on the gut microbiome [1].
One of the strengths of this study is that longitudinal measures of DNA methylation allowed
not only identifying regions of the methylome associated with breastfeeding, but also assessing if
those associations persist until adolescence. Dense phenotyping and genotyping of study participants
allowed controlling for several covariates, which were selected using a conceptual model defined
a priori. Moreover, DNA methylation data at birth was used as an attempt to identify associations
likely driven by residual confounding due to pre-natal factors. To unravel the possibility of residual
confounding by maternal smoking, we checked the overlap between the suggestive CpG sites from
our breastfeeding EWAS and the largest maternal smoking EWAS [55], and found that none of the sites
were amongst the 6073 sites that were associated with maternal smoking during pregnancy, making it
less likely that the associations were driven by residual confounding by maternal smoking. However,
residual confounding cannot be discounted due to missing confounders (including post-birth factors
that may affect breastfeeding quality and duration) measurement error and model misspecification [56].
Therefore, triangulating our findings with those from future studies using designs prone to different
potential sources of bias will be important to disentangle causality [57].
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In addition to the possibility of residual confounding, another weakness of our study is that our
exposure variable was ill-defined. Due to sample size constraints and limitations of self-reported data,
it was not possible to use more refined definitions of breastfeeding. Indeed, our main results were
related to the binary categorisation, which includes, in the “breastfed” group, highly heterogeneous
individuals regarding breastfeeding quality, duration, type of foods given concurrently with breastmilk
(for individuals that were non-exclusively breastfed) and after weaning, among other factors. Similarly,
the “non-breastfed” group potentially includes individuals that received many different types of foods.
This heterogeneity is likely to influence the results in ways that are rather difficult to predict and limits
the external validity of our findings.
With regards to the analysis on breastfeeding duration, we opted for a categorisation into groups
rather than the continuous breastfeeding variable because the latter is likely prone to substantial
measurement error and digit preference in the self-reported months of duration. Moreover, assuming
a linear effect over the entire range of breastfeeding duration (which entails assuming, for example
that the effect of changing from 0 to 1 month is the same as the effect of changing from 15 to 16 months)
seems less plausible than a linear trend over duration categories (which entails assuming, for example,
that the effect of changing from 0–3 to 3.01–6 months is the same as the effect of changing from 6.01–12
to >12 months). However, this categorisation did not show evidence of strong associations.
It should also be noted that our study was restricted to peripheral blood. As we discussed
elsewhere [22], DNA methylation in blood is unlikely to be a good proxy of DNA methylation in other
tissues, such as the brain [58–60], thus limiting the capacity of any breastfeeding EWAS using peripheral
blood to inform DNA methylation patterns in the target tissue [15,61]—in this example, when assessing
if the association between breastfeeding and IQ has a component related to methylation. This may also
limit the capacity to identify true signals. However, DNA methylation studies in surrogate tissues are
important. These are frequently the only viable alternative in large epidemiological studies, also being
able to provide useful information on the range of potential effects of the exposure of interest on DNA
methylation, which may then guide future, specific studies such as in vitro studies in cells and in vivo
studies in animal models [22].
Another important limitation is that we did not perform a formal replication of our results.
However, it is noteworthy that some hits (both in the CpG and DMR analysis) at age 7 years did not
present evidence of association at age 15–17 years. This indicates that inflation of type-I error due
to multiple-testing was not sufficient for a hit in one age to also present evidence of association in
other ages (otherwise, all hits at age 7 years would have also presented evidence of association at
age 15–17 years). Therefore, CpGs and DMRs that presented evidence of persistent associations are
less likely to be a sole product of multiple testing. However, this reasoning is less clear for transient
associations, which could be truly transient effects or merely false positives that do not carry over
to adolescence. Although persistent associations are likely to be more robust from a methodological
perspective in our study, this does not mean that transient effects are irrelevant. For example, they
could trigger the actual processes related to long-term effects (e.g., influences on brain development
and IQ in adulthood). Moreover, in our context transient effects mean that associations observed
at the age of 7 years did not persist until adolescence, but associations at age 7 would already be
persistent effects of breastfeeding. Finally, it is important to consider the loss of individuals to missing
data. About 30% of ARIES data were removed due to missing exposure, covariate or outcome data,
which reduces the power to find CpG sites related to breastfeeding. Methods for multiple imputation
in methylation data [62] are at an early stage and therefore were not used here, but in future these
methods will be crucial to maximise the power of an EWAS.
5. Conclusions
This study provides important insights into the magnitude and persistence of the association
between breastfeeding and peripheral blood DNA methylation. Rather than providing definitive
answers on their own, our results will serve to motivate future studies using different designs to
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improve causal inference, as well as consortium-based efforts—examples of which are already available
in the epigenetic epidemiology literature [55,63]—to achieve sample sizes large enough to both improve
power and allow replication. Such future efforts will complement and expand our findings by providing
robust evidence on the potential effects of breastfeeding on DNA methylation, which may contribute
to understand the biological basis of long-term associations between breastfeeding and health and
human capital outcomes, and potentially also reveal new biological aspects of breastfeeding.
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